ASH 2023: Exploring Therapeutic Advancements for Chronic Lymphocytic Leukemia - Episode 13
Expert oncologists explore emerging therapies being investigated in CLL, including BTKi degraders, CAR-T therapy, and bispecific antibodies, and discussed their potential impact in shaping the future of CLL treatment.